Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 5

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 5
---
us supplement, accompanying prospectus and any free writing prospectus that we have authorized for use in connection with this offering carefully, including the information incorporated by reference herein and therein, before deciding to invest in our common stock. Investors should carefully consider the information set forth under “Risk Factors” beginning on pageS-15
of this prospectus supplement, page 3 of the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement and accompanying prospectus.

Applied DNA Sciences, Inc.

Introduction

The Company is a biotechnology enterprise focused
on commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics sectors, while concurrently executing a
yield-oriented digital asset treasury strategy centered on BNB, the native cryptocurrency of the Binance blockchain.

The Company’s nucleic acid production solutions
enable cell-free manufacturing of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which are essential components for a new generation
of advanced biotherapeutics, such as gene therapies, adoptive cell therapies, messenger RNA therapeutics and DNA vaccines, as well as
diagnostic applications.

Our current strategy is to primarily focus our
resources on our BNB-focused treasury strategy wherein we manage digital assets, primarily in the native cryptocurrency of the Binance
Coin blockchain commonly referred to as “BNB”, including staking, restaking, and liquid staking of BNB, and participation
in other Binance ecosystem yield opportunities to contribute the BNB to the Company’s treasury operations (together, the “BNB
Strategy”). The Company intends to use the net proceeds from this offering primarily for the continued development and implementation
of our BNB Strategy, as well as for working capital and general corporate purposes. No assurance can be given that we will be successful
in our BNB Strategy. Currently, the Company is in the process of accumulating BNB tokens and plans to implement its strategies around
yield generation in the near future.

Private Placement Offering

As previously disclosed in our Current Reports
on Forms 8-K filed on September 29, 2025, October 1, 2025, and October 23, 2025, the Company completed the Cash Private
Placement (as defined below) on October 3, 2025 and completed the Cryptocurrency Private Placement (as defined below) on October 21,
2025 in which the Company: (i) entered into a securities purchase agreement (the “Cash Securities Purchase Agreement”)
with certain accredited investors (